| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $4.82 (Beat by $0.1) |
| EPS GAAP Actual | $4.82 (Beat by $0.1) |
| Revenue Actual | $1.839B |
| Revenue Surprise | Beat by $1839M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.94381 |
| EPS GAAP Estimate | $1.94381 |
| Revenue Estimate | $2.032523604B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 16.12 | 12.41 | 14.70409 | 17.14798 | 6 |
| Mar 2030 | 15.23 | 13.13 | 14.53778 | 16.07729 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.55 | -1.30223 | 1.839B | -10.49% | -304.21M |
| FQ2 2025 (Jun 2025) | 251 | 251 | 1.671B | 0.66% | 1671M |
| FQ1 2025 (Mar 2025) | 0.969 | 0.969 | 1.895B | 6.12% | 1895M |
| FQ4 2024 (Dec 2024) | 1.11 | 1.11 | 1.89B | -2.91% | 1890M |
| FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 2.032B | 5.81% | 2032M |
| FQ2 2024 (Jun 2024) | 266 | 266 | 1.66B | -15.9% | 1660M |
| FQ1 2024 (Mar 2024) | 267 | 267 | 1.779B | -5.34% | 1779M |
| FQ4 2023 (Dec 2023) | 269 | 269 | 1.945B | 3.29% | 1945M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.94381
Consensus Revenue Estimates
2.032523604B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.3867 | -- | 2.35625 | 2.44099 | 5 |
| FQ4 2027 (Dec 2027) | 4.11214 | -- | 4.05968 | 4.20568 | 4 |
| FQ3 2027 (Sep 2027) | 2.35562 | -- | 2.29265 | 2.44856 | 3 |
| FQ2 2027 (Jun 2027) | 0.49678 | -- | 0.4835 | 0.51638 | 5 |
| FQ1 2027 (Mar 2027) | 2.19504 | -- | 2.09012 | 2.24188 | 5 |
| FQ4 2026 (Oct 2026) | 2.28099 | -- | 2.12706 | 2.55914 | 7 |
| FQ3 2026 (Jul 2026) | 0.65626 | 16.19 | 0.61197 | 0.73629 | 4 |
| FQ2 2026 (Jun 2026) | 0.65626 | -38147.04 | 0.60807 | 0.74535 | 9 |
| FQ1 2026 (Mar 2026) | 1.94381 | 50.15 | 1.67111 | 2.28127 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.09B | -- | 2.07B | 2.13B | 5 |
| FQ4 2027 (Dec 2027) | 2.66B | -- | 2.63B | 2.7B | 6 |
| FQ3 2027 (Sep 2027) | 2.21B | -- | 2.17B | 2.28B | 6 |
| FQ2 2027 (Jun 2027) | 1.37B | -- | 1.35B | 1.42B | 6 |
| FQ1 2027 (Mar 2027) | 1.97B | -- | 1.9B | 2B | 5 |
| FQ4 2026 (Oct 2026) | 2.21B | -- | 2.09B | 2.41B | 8 |
| FQ3 2026 (Jul 2026) | 1.49B | -23.42 | 1.41B | 1.63B | 5 |
| FQ2 2026 (Jun 2026) | 1.49B | -12.15 | 1.41B | 1.65B | 6 |
| FQ1 2026 (Mar 2026) | 2.03B | 6.77 | 1.81B | 2.3B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.85223 | 0.55 | -1.30223 | -236.77% |
| FQ2 2025 (Jun 2025) | 251 | 251 | 100% | |
| FQ1 2025 (Mar 2025) | 0.969 | 0.969 | 100% | |
| FQ4 2024 (Dec 2024) | 1.11 | 1.11 | 100% | |
| FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 100% | |
| FQ2 2024 (Jun 2024) | 266 | 266 | 100% | |
| FQ1 2024 (Mar 2024) | 267 | 267 | 100% | |
| FQ4 2023 (Dec 2023) | 269 | 269 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.14B | $1.84B | $-304.21M | -16.54% |
| FQ2 2025 (Jun 2025) | $0B | $1.67B | $1671M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.9B | $1895M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.89B | $1890M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.03B | $2032M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.66B | $1660M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.78B | $1779M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.95B | $1945M | 100% |